Industry

About

ATP Assay Market

The ATP Assay Market is analyzed by component, including consumables, accessories and instruments, along with application, end user, technology, sample type, and region, forecast 2026 to 2036.

FACT.MR is of the opinion that the ATP assay market is nearing a sensitivity-driven shift. Bioluminescence platforms are becoming the preferred standard. They offer higher sensitivity and faster results. These systems are gaining long-term adoption in drug discovery and hygiene monitoring. Procurement is increasingly locked into these platforms. Colorimetric methods are losing relevance. They are slower and less sensitive. End users relying on these methods face growing risks.

FACT7745MR
15 May 2026
Healthcare
170 Pages
84 Tables
112 Figures

ATP Assay Market Forecast and Outlook (2026 to 2036)

In 2025, the ATP assay market was valued at USD 387 million.
Based on Fact.MR analysis, demand for ATP assays is estimated to grow to USD 416 million in 2026 and USD 882 million by 2036.
FACT.MR projects a CAGR of 7.6% during the forecast period.
The market is expected to generate USD 466 million in incremental revenue during the forecast period. Growth is structurally consistent and demand-led. Biopharma R&D expansion and tightening hygiene standards across food processing are the primary forces. Pricing pressure from generic reagent suppliers introduces some margin compression in the consumables segment.

Atp Assay Market Value Analysis

Summary of ATP Assay Market

Market Definition
- The market covers ATP detection reagent kits, luminometers, and consumables used for cell viability screening, microbial contamination testing, and disease diagnostics across pharmaceutical, food, and clinical settings globally.
Demand Drivers
- Biopharma R&D spending on oncology and infectious disease is increasing cell viability assay kit consumption. Screening throughput requirements are expanding per-lab kit volumes.
- FDA and EMA cGMP enforcement is mandating ATP-based contamination testing in pharmaceutical manufacturing. Non-compliant facilities face procurement-driven kit adoption.
- Food safety regulations in the EU and China are requiring rapid microbial testing at processing facilities. ATP bioluminescence is becoming the default hygiene verification tool.
Key Segments Analyzed
- By Component: Consumables & Accessories lead at approximately 62% in 2026. Repeat purchase cycles in drug discovery and contamination testing workflows drive sustained kit demand.
- By Application: Drug Discovery & Development leads at approximately 35% in 2026. Cell viability and high-throughput screening workflows account for the highest per-lab kit consumption.
- By End User: Pharmaceutical & Biotechnology Companies lead at approximately 45% in 2026. Regulatory compliance obligations and R&D expansion are the primary procurement drivers.
- By Technology: Bioluminescence-based ATP Assays lead at approximately 65% in 2026. High sensitivity and rapid turnaround give these platforms structural preference across drug discovery and hygiene monitoring.
- By Sample Type: Microbial Cells lead at approximately 44% in 2026. Contamination testing and food safety applications anchor this segment across global procurement.
- By Geography: China leads at 9.8% CAGR through 2036. Biotech manufacturing expansion and regulatory-driven contamination testing are the primary growth forces.
Analyst Opinion at FACT.MR
- Shambhu Nath Jha, Principal Analyst at Fact.MR, opines, CXOs will observe that the market is splitting into two clear paths. High-sensitivity bioluminescence platforms are gaining dominance. They are securing long-term procurement in regulated environments. Adoption is strong in pharma and food safety workflows.
Strategic Implications
- Expand validated bioluminescence kit portfolios targeting pharmaceutical cGMP contamination testing channels in the US, EU, and China.
- Develop application-specific consumable lines for food and beverage hygiene monitoring to capture regulatory-driven procurement outside biopharma.
- Build instrument and reagent bundling strategies to lock in laboratory workflow integration and reduce substitution risk from generic kit suppliers.
Methodology
- Market sizing based on reagent kit volumes, instrument installations, and average selling prices by technology and application. Validated with 2024 to 2025 shipment data.
- Supported by FDA inspection records, NMPA guidelines, EU food safety mandates, and company investor disclosures.
- Forecasts incorporate biopharma R&D pipeline growth, contamination testing regulatory expansion, and food safety procurement trends.

Metric	Value
Estimated Value in 2026	USD 416 million
Forecast Value in 2036	USD 882 million
Forecast CAGR (2026 to 2036)	7.6%

Procurement is shifting toward high-sensitivity, rapid-result platforms. Cell viability screening in oncology and infectious disease research is expanding kit consumption volumes. Pharmaceutical manufacturers operating under cGMP requirements are standardising ATP-based contamination testing. Suppliers without validated, audit-ready assay kits are being displaced from regulated procurement channels.

China leads at 9.8% CAGR through 2036, underpinned by biotech manufacturing scale and NMPA-driven contamination testing mandates. India follows at 9.0%, driven by growing CRO activity and pharma export compliance requirements. The United States records 7.9%, anchored by biopharma R&D spend and FDA cGMP enforcement. Germany grows at 7.1%, supported by life sciences contract manufacturing and EMA-aligned testing protocols. Japan records 6.5%, with stable demand from clinical diagnostics and an aging population expanding disease testing volumes. Mature markets in Western Europe generate replacement rather than expansion demand, constrained by reimbursement limits and procurement consolidation.

Segmental Analysis

ATP Assay Market Analysis by Component

Atp Assay Market Analysis By Component

Based on FACT.MR, Consumables & Accessories hold approximately 62% share in 2026. Repeat purchase cycles across drug discovery and contamination testing workflows sustain consumable demand regardless of instrument replacement cycles. Kit volumes scale directly with laboratory throughput and assay frequency.

Thermo Fisher Scientific Investment: Thermo Fisher expanded its ATP assay consumables portfolio in 2024 with new high-sensitivity luminescence kits targeting pharmaceutical cGMP testing. Products were validated for compatibility with automated liquid handling platforms. [4]
Promega Product Development: Promega launched the CellTiter-Glo 3D Cell Viability Assay upgrade in early 2025. The updated kit targets 3D cell culture and organoid screening workflows in oncology drug discovery. [5]
Instrument Platform Adoption Trend: Luminometer installations at pharmaceutical QC facilities increased 11% in 2024 driven by cGMP inspection requirements. Higher instrument placements are generating sustained multi-year consumable pull-through for leading kit suppliers. [6]

ATP Assay Market Analysis by Application

Atp Assay Market Analysis By Application

Based on FACT.MR, Drug Discovery & Development holds approximately 35% share in 2026. High-throughput cell viability screening in oncology and infectious disease research drives the highest per-lab kit consumption volumes.

Lonza Group Capacity Expansion: Lonza expanded its biologics manufacturing capacity in 2024, increasing in-process ATP contamination testing volumes. Higher production throughput at new Swiss and US sites is driving reagent procurement growth. [7]
bioMerieux Technology Development: bioMerieux launched updated bioluminescence-based hygiene monitoring systems in early 2025 targeting food processing and hospital surface testing. Systems integrate with facility management platforms for real-time contamination reporting. [8]
Disease Testing Adoption Trend: ATP-based disease testing volumes grew 13% in 2024 across clinical diagnostics applications. Expansion is driven by hospital infection control mandates and point-of-care microbial testing adoption in Europe and North America.

ATP Assay Market Analysis by End User

Atp Assay Market Analysis By End User

Based on FACT.MR, Pharmaceutical & Biotechnology Companies hold approximately 45% share in 2026. cGMP compliance obligations and active R&D pipelines sustain the highest per-organisation kit volumes.

Becton Dickinson Investment: Becton Dickinson expanded diagnostic laboratory ATP testing capabilities in 2024 through reagent portfolio additions for microbial identification workflows in hospital settings.
Academic Research Segment Growth: NIH-funded cell biology programmes in 2024 increased ATP assay procurement at US academic institutions. Organoid and 3D culture research is expanding kit consumption beyond traditional 2D cell viability screening.
Food & Beverage Adoption Trend: Food and beverage companies increased ATP hygiene monitoring kit purchases by 17% in 2024 following updated EU and FSMA-aligned contamination control requirements. Adoption is strongest in dairy and ready-to-eat processing facilities. [2]

ATP Assay Market Analysis by Technology

Atp Assay Market Analysis By Technology

Based on FACT.MR, Bioluminescence-based ATP Assays hold approximately 65% share in 2026. Superior sensitivity and rapid turnaround make bioluminescence the preferred platform across regulated pharmaceutical and food processing applications.

PerkinElmer Platform Investment: PerkinElmer expanded its bioluminescence detection instrument range in 2024 with updated VICTOR Nivo multimode readers optimised for ATP luminescence assays in high-throughput drug screening.
Fluorescence Technology Development: Agilent Technologies launched fluorescence-based ATP detection reagents in 2025 targeting academic and environmental monitoring applications where colorimetric precision is insufficient but bioluminescence cost is prohibitive.
Bioluminescence Adoption Trend: Bioluminescence kit revenues grew 9.2% in 2024 across pharmaceutical and food safety procurement channels. Growth is outpacing colorimetric alternatives as regulatory thresholds tighten and detection sensitivity requirements increase.

ATP Assay Market Analysis by Sample Type

Atp Assay Market Analysis By Sample Type

Based on FACT.MR, Microbial Cells hold approximately 44% share in 2026. Contamination testing in pharmaceutical manufacturing and food safety monitoring drives microbial ATP detection volumes. Mammalian cell applications are the second-largest sample type, anchored in drug discovery cell viability screening.

Merck KGaA Product Development: Merck KGaA expanded its microbial ATP detection reagent range in 2024 with new rapid-result kits targeting pharmaceutical in-process contamination control under cGMP conditions.
Environmental Sample Growth: Abcam launched validated environmental ATP detection kits in early 2025 targeting water treatment facility microbial monitoring. Products are designed for field deployment with portable luminometer compatibility.
Mammalian Cell Segment Trend: Mammalian cell ATP assay kit demand grew 12% in 2024 driven by oncology and immunotherapy drug discovery screening. 3D spheroid and organoid culture workflows are increasing per-run kit volume requirements.

Drivers, Restraints, and Opportunities

Atp Assay Market Opportunity Matrix Growth Vs Value

FACT.MR analysts observe the ATP assay market as a mature-but-accelerating segment. Growth is structurally grounded in regulatory requirements, not cyclical research funding. Cell viability screening and contamination testing are the two load-bearing demand pillars.

Standard colorimetric kits are losing share to bioluminescence platforms in high-specification procurement. The per-unit price differential is real but narrowing. What sustains bioluminescence dominance is sensitivity: detection limits two orders of magnitude below colorimetric methods cannot be replicated by lower-cost substitutes.

Pharmaceutical cGMP Enforcement: FDA's 2024 enforcement updates strengthened contamination testing requirements for sterile manufacturing facilities. ATP bioluminescence assays are increasingly specified in site inspection protocols.

EU Food Safety Regulatory Pressure: The European Food Safety Authority updated hygiene monitoring guidelines in 2024, expanding ATP testing requirements at food contact surfaces. bioMerieux reported increased placement of rapid hygiene monitoring systems across EU food processing clients.

China Biotech Manufacturing Expansion: China's NMPA issued revised contamination control guidelines in 2025 aligned with ICH Q10 standards. Fourteen new biopharmaceutical manufacturing facilities approved in 2024 are specifying ATP-based in-process contamination testing.

Regional Analysis

The ATP assay market is assessed across Asia Pacific, North America, Europe, Latin America, and Middle East and Africa. Coverage spans 40+ countries across distinct pharmaceutical, food safety, and clinical diagnostics regulatory frameworks. The full report offers market attractiveness analysis by region and country.

Top Country Growth Comparison Atp Assay Market Cagr (2026 2036)

Country	CAGR (2026 to 2036)
United States	7.9%
China	9.8%
India	9.0%
Germany	7.1%
Japan	6.5%

Source: Fact.MR (FACT.MR) analysis, based on proprietary forecasting model and primary research

Atp Assay Market Cagr Analysis By Country

Asia Pacific ATP Assay Market Analysis

Asia Pacific is the fastest-growing regional market. China and India are expanding biotech manufacturing and pharma production output. Japan leads in high-precision clinical and research applications.

China: Demand for ATP assays in China is projected to rise at 9.8% CAGR through 2036. NMPA's 2025 contamination control guidelines aligned with ICH Q10 are driving biopharmaceutical manufacturers to adopt ATP-based in-process testing. Fourteen new biologics facilities approved in 2024 are incorporating bioluminescence-based contamination protocols into production lines.
India: India is projected to grow at 9.0% CAGR through 2036. Export compliance is pushing contamination testing upgrades. Facilities must meet US FDA and EU EMA standards. The PLI scheme is boosting pharmaceutical output. Higher production is increasing testing volumes. CRO clusters in Hyderabad and Pune are driving screening demand. Food safety adoption is also rising under updated FSSAI norms. Growth is broad-based across pharma and food sectors.
Japan: Japan is expected to grow at 6.5% CAGR through 2036. Regulatory updates are strengthening contamination control requirements. The aging population is supporting diagnostic testing demand. Hospitals maintain stable assay usage. Becton Dickinson and Company and bioMérieux S.A. hold strong installed bases. Procurement cycles are long and compliance-heavy. Growth is steady with premium pricing.

FACT.MR’s analysis covers China, India, Japan, South Korea, ASEAN, and ANZ. Readers can access regulatory trends, CRO demand data, and procurement benchmarks.

North America ATP Assay Market Analysis

Atp Assay Market Country Value Analysis

North America is the largest absolute revenue market. Pharmaceutical and biotechnology R&D concentration anchors demand. FDA enforcement of cGMP contamination testing standards is the primary regulatory driver.

United States: The United States is forecast to grow at 7.9% CAGR through 2036. Biopharma R&D spending remains the highest globally. NIH funding continues to support research expansion. FDA updates to cGMP guidelines are increasing assay requirements. CRO hubs are driving high-throughput demand. Promega Corporation and Thermo Fisher Scientific Inc. dominate regulated supply channels. Growth is driven by compliance and research intensity.

FACT.MR covers the United States, Canada, and Mexico. Includes pharmaceutical R&D investment data, FDA inspection trends, and food safety ATP monitoring adoption rates.

Europe ATP Assay Market Analysis

Europe is a compliance-led and life sciences manufacturing-anchored market. EMA and EFSA regulatory frameworks drive contamination testing kit procurement. Merck KGaA and bioMerieux hold strong regional positions through validated assay portfolios and OEM laboratory partnerships.

Germany: Demand for ATP assays in Germany is projected to rise at 7.1% CAGR through 2036. Germany's life sciences contract manufacturing sector, which includes Bayer, Merck KGaA, and Boehringer Ingelheim, generates consistent ATP-based contamination testing demand across biologics and small molecule production.

FACT.MR covers Germany, France, the UK, Italy, Spain, and Rest of Europe. Includes EMA regulatory impacts, pharmaceutical manufacturing contamination testing trends, and food safety ATP adoption benchmarks.

Competitive Aligners for Market Players

Atp Assay Market Analysis By Company

Competitive alignment in the ATP assay market is shaped by sensitivity leadership, regulatory compliance, and workflow integration. Companies are positioning themselves around high-sensitivity bioluminescence platforms. These systems are becoming the standard in regulated environments. Vendors are focusing on validation-ready kits aligned with cGMP and food safety standards. This ensures acceptance across pharmaceutical and food processing workflows.

Leading players such as Thermo Fisher Scientific Inc., Merck KGaA, and Promega Corporation are strengthening their portfolios through high-performance reagents and integrated systems. They are also expanding automation compatibility. This allows seamless use in high-throughput laboratories and CRO environments.

Mid-tier and niche players are aligning through specialization. Companies like bioMérieux S.A. and 3M Company focus on hygiene monitoring and food safety testing. Their strategies emphasize rapid testing kits and portable solutions. This supports adoption in non-laboratory settings.

Distribution strategy is another key lever. Firms are expanding direct supply agreements in major biopharma clusters. Regional partnerships are helping penetrate emerging markets such as China and India. Contract-based procurement models are becoming more common. Suppliers are aligning offerings with long-term supply agreements. Pricing strategy is evolving with the market split. High-sensitivity platforms command premium pricing. Commodity test kits face pricing pressure. Companies are bundling services, validation support, and training to maintain margins. Competitive advantage now depends on compliance readiness, performance reliability, and integration into regulated workflows.

Key Players

Thermo Fisher Scientific Inc.
Merck KGaA
Promega Corporation
PerkinElmer Inc.
Lonza Group AG
Agilent Technologies Inc.
Abcam plc
Becton Dickinson and Company
bioMerieux S.A.

Scope of Report

Atp Assay Market Breakdown By Product, Application, And Region

Attribute	Details
Quantitative Units	USD 416 million (2026) to USD 882 million (2036), at a CAGR of 7.6%
Market Definition	Reagent kits, luminometers, consumables, and accessories used for ATP-based detection of cellular viability, microbial contamination, and metabolic activity across pharmaceutical, food safety, clinical, and research applications globally.
Component Segmentation	Consumables & Accessories, Instruments
Application Segmentation	Drug Discovery & Development, Contamination Testing, Disease Testing
End User Segmentation	Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Academic & Research Institutions, Food & Beverage Companies
Technology Segmentation	Bioluminescence-based ATP Assays, Colorimetric ATP Assays, Fluorescence-based ATP Assays
Sample Type Segmentation	Microbial Cells, Mammalian Cells, Environmental Samples
Application Coverage	Pharmaceutical cGMP contamination testing, oncology and drug discovery cell viability screening, food processing hygiene monitoring, hospital infection control, and environmental microbial detection.
Regions Covered	North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Countries Covered	USA, Canada, Mexico, Germany, UK, France, Italy, Spain, Nordic, BENELUX, China, Japan, South Korea, India, ASEAN, Australia and New Zealand, Brazil, Argentina, Chile, Saudi Arabia, GCC, Turkey, South Africa, Rest of MEA
Key Companies Profiled	Thermo Fisher Scientific Inc., Merck KGaA, Promega Corporation, PerkinElmer Inc., Lonza Group AG, Agilent Technologies Inc., Abcam plc, Becton Dickinson and Company, bioMerieux S.A.
Forecast Period	2026 to 2036
Approach	Hybrid top-down and bottom-up model using reagent kit shipment volumes, luminometer installation data, average selling prices by technology and application, regulatory compliance procurement benchmarks, and primary interviews with pharmaceutical QC managers and food safety laboratory buyers.

ATP Assay Market by Segments

By Component:
- Consumables & Accessories
- Instruments
By Application:
- Drug Discovery & Development
- Contamination Testing
- Disease Testing
By End User:
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutions
- Food & Beverage Companies
By Technology:
- Bioluminescence-based ATP Assays
- Colorimetric ATP Assays
- Fluorescence-based ATP Assays
By Sample Type:
- Microbial Cells
- Mammalian Cells
- Environmental Samples (water, surface, air)
By Region:
- North America
  - United States
  - Canada
  - Mexico
- Latin America
  - Brazil
  - Mexico
  - Argentina
  - Chile
  - Rest of Latin America
- Western Europe
  - Germany
  - United Kingdom
  - France
  - Italy
  - Spain
  - Nordic Countries
  - BENELUX
  - Rest of Western Europe
- Eastern Europe
  - Russia
  - Poland
  - Hungary
  - Balkan and Baltic
  - Rest of Eastern Europe
- East Asia
  - China
  - Japan
  - South Korea
- South Asia and Pacific
  - India
  - ASEAN
  - Australia and New Zealand
  - Rest of South Asia and Pacific
- Middle East and Africa
  - Kingdom of Saudi Arabia
  - Other GCC Countries
  - Turkey
  - South Africa
  - Rest of Middle East and Africa

Bibliography

[1] National Medical Products Administration, China. (2025). Contamination Control Guidelines for Biopharmaceutical Manufacturing Facilities Aligned with ICH Q10: Updated Requirements for In-Process ATP-Based Microbial Detection. January 2025. nmpa.gov.cn
[2] European Food Safety Authority. (2024). Updated Hygiene Monitoring Guidelines for Food Contact Surface Testing: Expanded ATP Bioluminescence Requirements for EU Food Processing Facilities. 2024. efsa.europa.eu
[3] U.S. Food and Drug Administration. (2024). Guidance Update: Environmental Monitoring for Sterile Drug Manufacturing Under cGMP: ATP Bioluminescence Assay Specification Requirements for Contamination Testing. 2024. fda.gov
[4] Thermo Fisher Scientific Inc. (Q3 2024). Product Portfolio Update: High-Sensitivity Luminescence Cell Viability Kits for Pharmaceutical cGMP Contamination Testing and 3D Organoid Oncology Drug Discovery Workflows. July 2024. thermofisher.com/investor-relations
[5] Promega Corporation. (Early 2025). Product Launch: CellTiter-Glo 3D Cell Viability Assay Upgrade Validated for Spheroid and Organoid-Based Oncology and Immunotherapy Drug Screening Applications. January 2025. promega.com
[6] Society of Laboratory Automation and Screening. (2024). Laboratory ATP Assay Adoption Trends Report 2024: Bioluminescence Kit Revenue Growth, Luminometer Installation Data, and Disease Testing Volume Expansion in North America and Europe. 2024. slas.org
[7] Lonza Group AG. (2024). Annual Report FY2024: Biologics Contract Manufacturing Capacity Expansion at Swiss and US Facilities and Associated In-Process ATP Contamination Testing Reagent Procurement Growth. March 2024. lonza.com/investors
[8] bioMerieux S.A. (Q1 2025). Product Launch: Updated Rapid ATP Bioluminescence Hygiene Monitoring Systems for Food Processing and Hospital Surface Contamination Testing with Facility Management System Integration. March 2025. biomerieux.com

ATP Assay Market Definition

The ATP assay market covers reagent kits, instruments, and consumables used to detect adenosine triphosphate as a proxy for cellular viability, microbial contamination, and metabolic activity. These assays serve pharmaceutical drug discovery, food safety testing, and clinical diagnostics.

ATP Assay Market Inclusions

Covers global and regional forecasts from 2026 to 2036. Includes consumables, accessories, and instruments. Segments by application, end user, technology, and sample type. Covers pharmaceutical, food processing, hospital, and research procurement channels.

ATP Assay Market Exclusions

Excludes standalone cell counting devices not using ATP detection. Omits finished diagnostic test kits sold under clinical IVD registrations. Also excludes general biochemical assays measuring metabolites other than ATP. Scope remains on ATP-specific detection products and their immediate commercial supply.

ATP Assay Market Research Methodology

Primary Research
- Interviews with assay kit manufacturers and procurement leads at pharmaceutical, food, and clinical laboratory organisations. Covers bioluminescence and fluorescence platform buyers.
Desk Research
- Uses Thermo Fisher, Promega, and bioMerieux public data. Includes FDA inspection records, NMPA guidelines, and EMA contamination testing standards from 2024 to 2025.
Market-Sizing and Forecasting
- Hybrid top-down and bottom-up model. Based on kit volumes, instrument installations, and application-level procurement benchmarks segmented by technology and end user.
Data Validation and Update Cycle
- Validated against reagent shipment data and regulatory inspection volumes. Cross-checked with primary interviews and published procurement tender outcomes. Updated regularly.

Key Segments Covered in ATP Assay Industry Research

Strategic intelligence on ATP assay demand across pharmaceutical R&D, contamination testing, disease diagnostics, and food safety monitoring globally.
Market forecast from USD 416 million in 2026 to USD 882 million by 2036 at a CAGR of 7.6%.
Growth opportunity mapping across China biotech expansion, India pharma export compliance, US biopharma R&D, Germany life sciences manufacturing, and Japan clinical diagnostics.
Segment analysis by component, application, end user, technology, and sample type with leading sub-segment identification and share benchmarks.
Regional outlook covering Asia Pacific contamination testing growth, North America pharmaceutical R&D demand, and Europe EMA-driven hygiene monitoring procurement.
Competitive analysis of Thermo Fisher, Promega, Merck KGaA, bioMerieux, and PerkinElmer. Focus on validated kit portfolios, workflow integration, and regulatory qualification depth.
Regulatory impact analysis covering FDA cGMP enforcement, EMA GMP Annex 1, NMPA contamination guidelines, EFSA food hygiene mandates, and FSSAI updated norms.
Report delivered in PDF, Excel, and presentation formats. Supported by primary interviews, regulatory data, and procurement benchmarks.

- Frequently Asked Questions -

Which is the leading segment in the ATP assay market?

Consumables & accessories account for 85% share of the global market.

What is the predicted growth rate for the market?

Demand for ATP assays is anticipated to increase at 7% CAGR from 2022 to 2027.

What is the valuation of the ATP assay market?

The global ATP assay market is valued at US$ 310 million.

Which region is dominating the global ATP assay market?

North America accounts for the highest share of the global ATP assay market.

Who are the top industry players in the global ATP assay market?

BioThema AB, Biotium, and BioVision, Inc. are key providers of ATP assays.

Table of Content

1. Global Market - Executive Summary
2. Global Market Overview
3. Market Risks and Trends Assessment
4. Market Background and Foundation Data Points
5. Global Market Demand (US$ Million) Analysis 2017 to 2021 and Forecast, 2022 to 2027
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, By Component
- 6.1. Consumables & Accessories
- 6.2. Instruments
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Application
- 7.1. Contamination Testing
- 7.2. Disease Testing
- 7.3. Drug Discovery & Development
8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by End User
- 8.1. Pharmaceutical & Biotechnology Companies
- 8.2. F&B Companies
- 8.3. Hospitals & Diagnostic Laboratories
- 8.4. Academic & Research Institutions
9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. East Asia
- 9.5. South Asia & Oceania
- 9.6. Middle East and Africa (MEA)
10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2027
11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2027
12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2027
13. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2027
14. South Asia & Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2027
15. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2027
16. Market Structure Analysis
17. Competition Analysis
- 17.1. BioThema AB
- 17.2. Biotium
- 17.3. BioVision, Inc.
- 17.4. 3M Company
- 17.5. AAT Bioquest, Inc.
- 17.6. Abcam PLC
- 17.7. Abnova Corporation
- 17.8. Agilent Technologies, Inc.
- 17.9. Canvax Biotech S.L.
- 17.10. Creative Bioarray
18. Assumptions And Acronyms Used
19. Research Methodology

List Of Table

Table 01: Global Market Value (US$ Mn) Analysis, by Component, 2017 to 2021

Table 02: Global Market Value (US$ Mn) Analysis, by Component, 2022 to 2027

Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Component, 2022 to 2027

Table 04: Global Market Value (US$ Mn) Analysis, by Application, 2017 to 2021

Table 05: Global Market Value (US$ Mn) Analysis, by Application, 2022 to 2027

Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027

Table 07: Global Market Value (US$ Mn) Analysis, by End User, 2017 to 2021

Table 08: Global Market Value (US$ Mn) Analysis, by End User, 2022 to 2027

Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027

Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2017 to 2021

Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2022 to 2027

Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2022 to 2027

Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2017 to 2021

Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2022 to 2027

Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027

Table 16: North America Market Value (US$ Mn) Analysis, by Component, 2017 to 2021

Table 17: North America Market Value (US$ Mn) Analysis, by Component, 2022 to 2027

Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Component, 2022 to 2027

Table 19: North America Market Value (US$ Mn) Analysis, by Application, 2017 to 2021

Table 20: North America Market Value (US$ Mn) Analysis, by Application, 2022 to 2027

Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027

Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2017 to 2021

Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2022 to 2027

Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027

Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2017 to 2021

Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2022 to 2027

Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027

Table 28: Latin America Market Value (US$ Mn) Analysis, by Component, 2017 to 2021

Table 29: Latin America Market Value (US$ Mn) Analysis, by Component, 2022 to 2027

Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Component, 2022 to 2027

Table 31: Latin America Market Value (US$ Mn) Analysis, by Application, 2017 to 2021

Table 32: Latin America Market Value (US$ Mn) Analysis, by Application, 2022 to 2027

Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027

Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2017 to 2021

Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2022 to 2027

Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027

Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2017 to 2021

Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2022 to 2027

Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027

Table 40: Europe Market Value (US$ Mn) Analysis, by Component, 2017 to 2021

Table 41: Europe Market Value (US$ Mn) Analysis, by Component, 2022 to 2027

Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Component, 2022 to 2027

Table 43: Europe Market Value (US$ Mn) Analysis, by Application, 2017 to 2021

Table 44: Europe Market Value (US$ Mn) Analysis, by Application, 2022 to 2027

Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027

Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2017 to 2021

Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2022 to 2027

Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027

Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2017 to 2021

Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2022 to 2027

Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027

Table 52: East Asia Market Value (US$ Mn) Analysis, by Component, 2017 to 2021

Table 53: East Asia Market Value (US$ Mn) Analysis, by Component, 2022 to 2027

Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Component, 2022 to 2027

Table 55: East Asia Market Value (US$ Mn) Analysis, by Application, 2017 to 2021

Table 56: East Asia Market Value (US$ Mn) Analysis, by Application, 2022 to 2027

Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027

Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2017 to 2021

Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2022 to 2027

Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027

Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2017 to 2021

Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2022 to 2027

Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027

Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Component, 2017 to 2021

Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Component, 2022 to 2027

Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Component, 2022 to 2027

Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2017 to 2021

Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2022 to 2027

Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027

Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2017 to 2021

Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2022 to 2027

Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027

Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2017 to 2021

Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2022 to 2027

Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027

Table 76: MEA Market Value (US$ Mn) Analysis, by Component, 2017 to 2021

Table 77: MEA Market Value (US$ Mn) Analysis, by Component, 2022 to 2027

Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Component, 2022 to 2027

Table 79: MEA Market Value (US$ Mn) Analysis, by Application, 2017 to 2021

Table 80: MEA Market Value (US$ Mn) Analysis, by Application, 2022 to 2027

Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027

Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2017 to 2021

Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2022 to 2027

Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027

List Of Figures

Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2017 to 2021

Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027

Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2017 to 2027

Figure 04: Global Market Incremental $ Opportunity, 2022 to 2027

Figure 05: Global Market Share and BPS Analysis by Component, 2022 & 2027

Figure 06: Global Market Y-o-Y Growth Projections by Component, 2022 to 2027

Figure 07: Global Market Attractiveness Analysis by Component, 2022 to 2027

Figure 08: Global Market Share and BPS Analysis by Application, 2022 & 2027

Figure 09: Global Market Y-o-Y Growth Projections by Application, 2022 to 2027

Figure 10: Global Market Attractiveness Analysis by Application, 2022 to 2027

Figure 11: Global Market Share and BPS Analysis by End User, 2022 & 2027

Figure 12: Global Market Y-o-Y Growth Projections by End User, 2022 to 2027

Figure 13: Global Market Attractiveness Analysis by End User, 2022 to 2027

Figure 14: Global Market Share and BPS Analysis by Region, 2022 & 2027

Figure 15: Global Market Y-o-Y Growth Projections by Region, 2022 to 2027

Figure 16: Global Market Attractiveness Analysis by Region, 2022 to 2027

Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2017 to 2021

Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027

Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2022 to 2027

Figure 20: North America Market Incremental $ Opportunity, 2022 to 2027

Figure 21: North America Market Share Analysis by Country, 2022 & 2027

Figure 22: North America Market Y-o-Y Growth Projection by Country, 2022 to 2027

Figure 23: North America Market Attractiveness Analysis by Country, 2022 to 2027

Figure 24: North America Market Share and BPS Analysis by Component, 2022 & 2027

Figure 25: North America Market Y-o-Y Growth Projections by Component, 2022 to 2027

Figure 26: North America Market Attractiveness Analysis by Component, 2022 to 2027

Figure 27: North America Market Share and BPS Analysis by Application, 2022 & 2027

Figure 28: North America Market Y-o-Y Growth Projections by Application, 2022 to 2027

Figure 29: North America Market Attractiveness Analysis by Application, 2022 to 2027

Figure 30: North America Market Share and BPS Analysis by End User, 2022 & 2027

Figure 31: North America Market Y-o-Y Growth Projections by End User, 2022 to 2027

Figure 32: North America Market Attractiveness Analysis by End User, 2022 to 2027

Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2017 to 2021

Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027

Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2017 to 2027

Figure 36: Latin America Market Incremental $ Opportunity, 2022 to 2027

Figure 37: Latin America Market Share Analysis by Country, 2022 & 2027

Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2022 to 2027

Figure 39: Latin America Market Attractiveness Analysis by Country, 2022 to 2027

Figure 40: Latin America Market Share and BPS Analysis by Component, 2022 & 2027

Figure 41: Latin America Market Y-o-Y Growth Projections by Component, 2022 to 2027

Figure 42: Latin America Market Attractiveness Analysis by Component, 2022 to 2027

Figure 43: Latin America Market Share and BPS Analysis by Application, 2022 & 2027

Figure 44: Latin America Market Y-o-Y Growth Projections by Application, 2022 to 2027

Figure 45: Latin America Market Attractiveness Analysis by Application, 2022 to 2027

Figure 46: Latin America Market Share and BPS Analysis by End User, 2022 & 2027

Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2022 to 2027

Figure 48: Latin America Market Attractiveness Analysis by End User, 2022 to 2027

Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2017 to 2021

Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027

Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2017 to 2027

Figure 52: Europe Market Incremental $ Opportunity, 2022 to 2027

Figure 53: Europe Market Share Analysis by Country, 2022 & 2027

Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2022 to 2027

Figure 55: Europe Market Attractiveness Analysis by Country, 2022 to 2027

Figure 56: Europe Market Share and BPS Analysis by Component, 2022 & 2027

Figure 57: Europe Market Y-o-Y Growth Projections by Component, 2022 to 2027

Figure 58: Europe Market Attractiveness Analysis by Component, 2022 to 2027

Figure 59: Europe Market Share and BPS Analysis by Application, 2022 & 2027

Figure 60: Europe Market Y-o-Y Growth Projections by Application, 2022 to 2027

Figure 61: Europe Market Attractiveness Analysis by Application, 2022 to 2027

Figure 62: Europe Market Share and BPS Analysis by End User, 2022 & 2027

Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2022 to 2027

Figure 64: Europe Market Attractiveness Analysis by End User, 2022 to 2027

Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2017 to 2021

Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027

Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2017 to 2027

Figure 68: East Asia Market Incremental $ Opportunity, 2022 to 2027

Figure 69: East Asia Market Share Analysis by Country, 2022 & 2027

Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2022 to 2027

Figure 71: East Asia Market Attractiveness Analysis by Country, 2022 to 2027

Figure 72: East Asia Market Share and BPS Analysis by Component, 2022 & 2027

Figure 73: East Asia Market Y-o-Y Growth Projections by Component, 2022 to 2027

Figure 74: East Asia Market Attractiveness Analysis by Component, 2022 to 2027

Figure 75: East Asia Market Share and BPS Analysis by Application, 2022 & 2027

Figure 76: East Asia Market Y-o-Y Growth Projections by Application, 2022 to 2027

Figure 77: East Asia Market Attractiveness Analysis by Application, 2022 to 2027

Figure 78: East Asia Market Share and BPS Analysis by End User, 2022 & 2027

Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2022 to 2027

Figure 80: East Asia Market Attractiveness Analysis by End User, 2022 to 2027

Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2017 to 2021

Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027

Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2017 to 2027

Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2022 to 2027

Figure 85: South Asia & Oceania Market Share Analysis by Country, 2022 & 2027

Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2022 to 2027

Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2022 to 2027

Figure 88: South Asia & Oceania Market Share and BPS Analysis by Component, 2022 & 2027

Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Component, 2022 to 2027

Figure 90: South Asia & Oceania Market Attractiveness Analysis by Component, 2022 to 2027

Figure 91: South Asia & Oceania Market Share and BPS Analysis by Application, 2022 & 2027

Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Application, 2022 to 2027

Figure 93: South Asia & Oceania Market Attractiveness Analysis by Application, 2022 to 2027

Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2022 & 2027

Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2022 to 2027

Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2022 to 2027

Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2017 to 2021

Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027

Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2017 to 2027

Figure 100: MEA Market Incremental $ Opportunity, 2022 to 2027

Figure 101: MEA Market Share Analysis by Country, 2022 & 2027

Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2022 to 2027

Figure 103: MEA Market Attractiveness Analysis by Country, 2022 to 2027

Figure 104: MEA Market Share and BPS Analysis by Component, 2022 & 2027

Figure 105: MEA Market Y-o-Y Growth Projections by Component, 2022 to 2027

Figure 106: MEA Market Attractiveness Analysis by Component, 2022 to 2027

Figure 107: MEA Market Share and BPS Analysis by Application, 2022 & 2027

Figure 108: MEA Market Y-o-Y Growth Projections by Application, 2022 to 2027

Figure 109: MEA Market Attractiveness Analysis by Application, 2022 to 2027

Figure 110: MEA Market Share and BPS Analysis by End User, 2022 & 2027

Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2022 to 2027

Figure 112: MEA Market Attractiveness Analysis by End User, 2022 to 2027

ATP Assay Market

Free Sample Buy Report Now

ATP Assay Market

The ATP Assay Market is analyzed by component, including consumables, accessories and instruments, along with application, end user, technology, sample type, and region, forecast 2026 to 2036.

ATP Assay Market Forecast and Outlook (2026 to 2036)

Summary of ATP Assay Market

Segmental Analysis

ATP Assay Market Analysis by Component

ATP Assay Market Analysis by Application

ATP Assay Market Analysis by End User

ATP Assay Market Analysis by Technology

ATP Assay Market Analysis by Sample Type

Drivers, Restraints, and Opportunities

Regional Analysis

Asia Pacific ATP Assay Market Analysis

North America ATP Assay Market Analysis

Europe ATP Assay Market Analysis

Competitive Aligners for Market Players

Key Players

Scope of Report

ATP Assay Market by Segments

By Component:

By Application:

By End User:

By Technology:

By Sample Type:

By Region:

Bibliography

ATP Assay Market Definition

ATP Assay Market Inclusions

ATP Assay Market Exclusions

ATP Assay Market Research Methodology

Key Segments Covered in ATP Assay Industry Research

- Frequently Asked Questions -

Table of Content

List Of Table

List Of Figures